JesusGBerdejaMD

Clinical Trials

• IMGN901 in Combination With Lenalidomide and Dexamethasone Start of enrollment: 2009 Dec 01

  Completed

  Phase 1

• Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy Start of enrollment: 2010 May 01

  Completed

  Phase 2

• Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Start of enrollment: 2011 Jul 01

  Completed

• Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma Start of enrollment: 2012 Jul 12

  Completed

  Phase 1

• A Study of LY2784544 in Participants With Myeloproliferative Neoplasms Start of enrollment: 2012 May 22

  Active, not recruiting

  Phase 2

• A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving Start of enrollment: 2012 Sep 01

  Completed

  Phase 1

• Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma Start of enrollment: 2012 Mar 01

  Unknown status

  Phase 1, Phase 2

• Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia Start of enrollment: 2012 Dec 13

  Completed

  Phase 3

• Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma Start of enrollment: 2012 Dec 01

  Completed

  Phase 1

• Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA Start of enrollment: 2013 Dec 01

  Completed

  Phase 2

• Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors Start of enrollment: 2014 Feb 01

  Completed

  Phase 1

• Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Start of enrollment: 2014 Jun 30

  Completed

  Phase 1, Phase 2

• Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL Start of enrollment: 2014 Jun 01

  Terminated

  Phase 2

• A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma Start of enrollment: 2014 Jul 15

  Completed

  Phase 1

• Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Start of enrollment: 2015 Jan 01

  Terminated

  Phase 2

• Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients Start of enrollment: 2016 Sep 21

  Completed

  Phase 2

• Join now to see all